Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giulia Grazia
Observed names:
G Grazia,
G. Grazia,
GIULIA GRAZIA,
GRAZIA, GIULIA
Institution:
Beckman Coulter (United States)
Observed institutions:
University of Milan,
Istituto Tumori Bari,
IRCCS Ospedale San Raffaele,
Fondazione IRCCS Istituto Nazionale dei Tumori,
Beckman Coulter (United States),
Bayer (Germany)
show all 6
ORCID:
0000-0003-2411-3555
Observed ORCID:
0000-0003-2411-3555
OpenAlex ID:
A5031620548
Heme catabolism by tumor-associated macrophages controls metastasis formation
2021
·
Francesca Maria Consonni
, Augusto Bleve
, et al.
·
Nature Immunology
·
126
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
2020
·
Arianna Brevi
, Laura Lucia Cogrossi
, et al.
·
Frontiers in Immunology
·
118
PDF
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
2019
·
Fabio Pagni
, Elena Guerini-Rocco
, et al.
·
International Journal of Molecular Sciences
·
64
PDF
Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non–Small Cell Lung Cancer
2016
·
Elena Tassi
, Giulia Grazia
, et al.
·
Cancer Research
·
58
An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
2019
·
Valentina Perotti
, Paola Baldassari
, et al.
·
Oncogene
·
53
PDF
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker
2019
·
Diego Signorelli
, Patrizia Giannatempo
, et al.
·
BioMed Research International
·
48
PDF
The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy
2018
·
Andrea Anichini
, Elena Tassi
, et al.
·
Cancer Immunology Immunotherapy
·
46
Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
2014
·
GIULIA GRAZIA
, ILARIA PENNA
, et al.
·
International Journal of Oncology
·
38
PDF
Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade
2015
·
Ilaria Penna
, Alessandra Molla
, et al.
·
Oncotarget
·
30
PDF
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure
2016
·
Andrea Necchi
, Andrea Anichini
, et al.
·
Clinical Genitourinary Cancer
·
28
Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
2014
·
G Grazia
, C Vegetti
, et al.
·
Cell Death and Disease
·
22
PDF
An open-label, single-group, phase 2 study of brentuximab vedotin as salvage therapy for males with relapsed germ-cell tumors (GCT): Results at the end of first stage (FM12GCT01).
2016
·
Andrea Necchi
, Domenico Magazzu
, et al.
·
Journal of Clinical Oncology
·
17
A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy
2019
·
Alessandro Satta
, Giulia Grazia
, et al.
·
Frontiers in Immunology
·
12
PDF
Co-targeting of Oncogenic and Death Receptors Pathways in Human Melanoma:pre-clinical Rationale for a Pro-apoptotic and Anti-angiogenic Strategy
2016
·
GRAZIA, GIULIA
·
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
·
1
P0036 The presence of clustered circulating tumour cells (CTCS) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer
2014
·
R. Divella
, A. Mazzocca
, et al.
·
European Journal of Cancer
·
1
A Fully Automated, Walkaway Flow Cytometry Workflow for Immune Cell Subsets Identification
2024
·
Rita Bowers
, Giulia Grazia
, et al.
·
The Journal of Immunology
A new automatic gating algorithm replicates expert manual gating of immune cell subsets
2023
·
Nicole Yvonne Weit
, Rita Bowers
, et al.
·
The Journal of Immunology
PDF
Leveraging assay standardization with DURAClone dry antibody panels on six different flow cytometry platforms
2023
·
Rita Bowers
, Giulia Grazia
, et al.
·
The Journal of Immunology
PDF
Supplementary Tables S1 and S2 from Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non–Small Cell Lung Cancer
2023
·
Elena Tassi
, Giulia Grazia
, et al.
Data from Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non–Small Cell Lung Cancer
2023
·
Elena Tassi
, Giulia Grazia
, et al.
Supplementary Figures S1 through S28 from Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non–Small Cell Lung Cancer
2023
·
Elena Tassi
, Giulia Grazia
, et al.
Data from Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non–Small Cell Lung Cancer
2023
·
Elena Tassi
, Giulia Grazia
, et al.
Evaluation of dry DURAClone antibody panels for the characterization of human PBMCs, enriched T cell fractions and anti-BCMA CAR-T cells
2022
·
Rita Bowers
, Giulia Grazia
, et al.
·
The Journal of Immunology
21 An open-label, single-group, phase 2 study of brentuximab vedotin as salvage therapy for males with relapsed germ-cell tumours (GCT): Results at the end of first stage (FM12GCT01)
2016
·
A. Necchi
, D. Magazzu’
, et al.
·
European Urology Supplements
960 Combining Vascular Disruption Activity of TRAIL-expressing CD34+ Cells With Antiangiogenic Activity of Sorafenib Improves Regression of Tumor Growth
2012
·
A. Giacomini
, C. Lavazza
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
26
Citation count:
662
H-index:
12
I10-index:
13
Year
Topic
Type